Opinion|Videos|August 1, 2024

Unmet Needs in IPF Landscape

Critical voids in the management of idiopathic pulmonary fibrosis are discussed by Justin Oldham, MD, MS.

Video content above is prompted by the following:

  • What are the current unmet needs in IPF treatment and why is it necessary to develop new pharmacotherapies for this disease?
  • What biomarkers are currently used for the diagnosis of IPF?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo